Jos Lunenberg, GENALICE’s Chief Business Officer, comments: “It was impressive to see how well the Intel Xeon processors perform, when properly coded software is built around it. We now have agreed to team-up with Intel to even further improve their commodity processor to process DNA data.”
“There’s great analogy with video data processing, which started on Big Iron to end-up on a small chip,” adds Hans Karten, GENALICE’s CEO/CTO. “We are extremely excited to start this partnership, as this will allow us to further optimize this hardware/software combination to meet the big data challenge in medicine. Together we can now offer healthcare providers a bridge to personalized medicine by processing the sequenced full genome data of a patient’s cancer faster, better and more cost-effective than ever before.
In this partnership Intel will also become the main hardware supplier of GENALICE. Its product MAP is delivered to customer in a turn-key appliance, the GENALICE VAULT, which includes workflow management, tracking and real-time monitoring software, an embedded Oracle database and a storage solution.